Table 1 Comparison AOFAS scores (Group1=32,Group2=20; female=36, male=14)
AOFAS scores
|
Group1
|
Group2
|
p
|
male
|
female
|
p
|
Preoperative
|
64.3±2.54
|
63.1±2.31
|
0.196
|
64.3±2.75
|
63.7±2.43
|
0.892
|
4 months postoperatively
|
83.6 ±2.18
|
84. 1 ±1.84
|
0.411
|
83.1 ±2.09
|
84.0±2.01
|
0.532
|
12 months postoperatively
|
82.8±3.25
|
83.9±1.57
|
0.209
|
82.7±3.36
|
83.4±2.55
|
0.103
|
The p-values were determined using independent sample t-test. Significance levels are one symbol: p < 0.05.
Non-significant difference between preoperative AOFAS scores in group 1 and group 2.
Non-significant difference of AOFAS scores group 1 and group 2 after 4 months.
Non-significant difference of AOFAS scores in group 1 and group 2 after 12 months.
Non-significant difference of gender group 1 and group 2.
Table 2 Comparison VAS scores (Group1=32,Group2=20; female=36, male=14)
VAS scores
|
Group1
|
Group2
|
p
|
male
|
female
|
p
|
Preoperative
|
4.5±1.01
|
4.7±0.92
|
0.606
|
4.9±0.73
|
4.4±1.03
|
0.133
|
4 months postoperatively
|
2.0 ±0.73
|
2.1 ±0.67
|
0.872
|
1.9±0.62
|
2.2 ±0.72
|
0.517
|
12 months postoperatively
|
1.7± 0.43
|
1.7±0.55
|
0.303
|
1.6± 0.49
|
1.8± 0.47
|
0.291
|
The p-values were determined using independent sample t-test. Significance levels are one symbol: p < 0.05.
Non-significant difference between preoperative VAS scores e in group 1 and group 2.
Non-significant difference of VAS scores in group 1 and group 2 after 4 months.
Non-significant difference of VAS scores in group 1 and group 2 after 12 months.
Non-significant difference of gender group 1 and group 2.
Table3 Comparison different time (Group1)(n=32)
|
AOFAS
|
VAS
|
HVA
|
IMA
|
Preoperative
|
63.1±2.31
|
4.7±0.92
|
46.4 ±3.28
|
18.5 ±1.98
|
4 months postoperatively
|
84. 1 ±1.84
|
2.1 ±0.67
|
18.9 ±3.06
|
8.89±1.39
|
12 months postoperatively
|
83.9±1.57
|
1.7±0.55
|
19.9 ±4.70
|
9.25 ±1.11
|
F
|
519.23
|
119.27
|
535.68
|
340.20
|
p
|
<0.05
|
<0.05
|
<0.05
|
<0.05
|
pa
|
0.000
|
0.000
|
0.000
|
0.000
|
pb
|
0.000
|
0.000
|
0.000
|
0.000
|
pc
|
0.694
|
0.229
|
0.286
|
0.016
|
pa compare the results between preoperative with 4 months postoperatively .
pb compare the results between preoperative with 12 months postoperatively.
pc compare the results between 4 months with 12 months postoperatively.
Table4 Comparison different time (Group2) (n=20)
|
AOFAS
|
VAS
|
HVA
|
IMA
|
Preoperative
|
64.3±2.54
|
4.5±1.01
|
45.1 ±3.45
|
18.3 ±1.81
|
4 months postoperatively
|
83.6 ±2.18
|
2.0 ±0.73
|
17.5 ±2.97
|
8.34 ±1.45
|
12 months postoperatively
|
82.8±3.25
|
1.7± 0.43
|
19.1 ±4.70
|
9.53 ±1.70
|
F
|
776.7
|
95.7
|
343.3
|
247.6
|
p
|
<0.05
|
<0.05
|
<0.05
|
<0.05
|
pa
|
0.000
|
0.000
|
0.000
|
0.000
|
pb
|
0.000
|
0.000
|
0.000
|
0.000
|
pc
|
1.000
|
0.268
|
1.000
|
1.000
|
pa compare the results between preoperative with 4 months postoperatively .
pb compare the results between preoperative with 12 months postoperatively.
pc compare the results between 4 months with 12 months postoperatively.
Table 5 Comparison HVA (Group1=32,Group2=20; female=36, male=14)
HVA
|
Group1
|
Group2
|
p
|
male
|
female
|
p
|
Preoperative
|
45.1 ±3.45
|
46.4 ±3.28
|
0.749
|
45.9±3.60
|
45.4±3.39
|
0.762
|
4 months postoperatively
|
17.5 ±2.97
|
18.9 ±3.06
|
0.984
|
17.9±3.39
|
18.2 ±2.97
|
0.632
|
12 months postoperatively
|
19.1 ±4.70
|
19.9 ±4.70
|
0.647
|
18.6± 3.81
|
19.7± 4.96
|
0.886
|
The p-values were determined using independent sample t-test. Significance levels are one symbol: p < 0.05.
Non-significant difference between preoperative HVA in group 1 and group 2.
Non-significant difference of HVA in group 1 and group 2 after 4 months.
Non-significant difference of HVA in group 1 and group 2 after 12 months.
Non-significant difference of gender group 1 and group 2.
Table6 Comparison IMA (Group1=32,Group2=20; female=36, male=14)
IMA
|
Group1
|
Group2
|
p
|
male
|
female
|
|
p
|
Preoperative
|
18.3 ±1.81
|
18.5 ±1.98
|
0.338
|
19.7±2.22
|
18.8±1.45
|
|
0.102
|
4 months postoperatively
|
8.34 ±1.45
|
8.89±1.39
|
0.913
|
8.1±1.70
|
8.7 ±1.32
|
|
0.854
|
12 months postoperatively
|
9.53 ±1.70
|
9.25 ±1.11
|
0.308
|
8.9± 1.07
|
9.6± 1.60
|
|
0.228
|
The p-values were determined using independent sample t-test. Significance levels are one symbol: p < 0.05.
Non-significant difference between preoperative IMA n group 1 and group 2.
Non-significant difference of IMA in group 1 and group 2 after 4 months.
Non-significant difference of IMA in group 1 and group 2 after 12 months.
Non-significant difference of gender group 1 and group 2.
Table 7 Comparison Complications in two groups (Group1=32,Group2=20)
Complications
|
Group1
|
Group2
|
Hallux varus deformity
|
0
|
0
|
The first metatarsal dorsal elevation
|
4
|
0
|
Recurrence of HV with transfer metatarsalgia
|
2
|
0
|
Nerve injury
|
2
|
1
|
Skin infection
|
0
|
0
|
Stiffness of first MTP
|
0
|
0
|